MicroRNA expression profiling of nasopharyngeal carcinoma

Oncology Reports

Volumn 25, Issue 5, 2011, Pages 1353-1363

  Li, Ting ^a   Chen, Jia Xin ^b   Fu, Xu Ping ^a   Yang, Shu ^a   Zhang, Zheng ^b   Chen, Kh He ^b   Li, Yao ^a  

^a FUDAN UNIVERSITY   (China)

^b People's Hospital   (China)

Author keywords

Differentially expressed gene; Microarray; microRNA; Nasopharyngeal carcinoma; Pathway enrichment

Indexed keywords

MICRORNA; MYC PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HEARING; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; NASOPHARYNX CARCINOMA; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VALIDATION PROCESS;

ADULT; AGED; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-MYC; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 79953030875     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1204     Document Type: Article

References (56)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
2. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
3. Wu L, Fan J and Belasco JG: MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci 103: 4034-4039, 2006.
4. Calin GA, Dumitru CD, Shimizu M, et al: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529, 2002. (Pubitemid 35403967)
5. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
6. Johnson SM, Grosshans H, Shingara J, et al: RAS is regulated by the let-7 microRNA family. Cell 120: 635-647, 2005. (Pubitemid 40343076)
7. Wei WI and Sham JST: Nasopharyngeal carcinoma. Lancet 365: 2041-2054, 2005. (Pubitemid 40812341)
8. Zhang L, Deng T, Li X, et al: microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis 31: 559-566, 2010.
9. Xia H, Ng SS, Jiang S, et al: miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun 391: 535-541, 2010.
10. Wong TS, Man OY, Tsang CM, et al: MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. J Cancer Res Clin Oncol: May 4, 2010 (Epub ahead of print).
11. Shi W, Alajez NM, Bastianutto C, et al: Significance of P1k1 regulation by miR-100 in human nasopharyngeal cancer. Int J Cancer 126: 2036-2048, 2010.
12. Chen HC, Chen GH, Chen YH, et al: MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer 100: 1002-1011, 2009.
13. Sengupta S, Den Boon JA and Chen I: MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA 105: 5874-5878, 2008. (Pubitemid 351758465)
14. Lin SM, Du P, Huber W and Kibbe WA: Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res 36: e11, 2008.
15. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001. (Pubitemid 32397092)
16. Eisen MB, Spellman PT, Brown PO and Botstein D: Quster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868, 1998. (Pubitemid 29003722)
17. Ozen M, Creighton CJ, Ozdemir M and Ittmann M: Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27: 1788-1793, 2008. (Pubitemid 351380263)
18. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell 115: 787-798, 2003. (Pubitemid 38058492)
19. John B, Enright AJ, Aravin A, Tuschl T, Sander C and Marks DS: Human MicroRNA targets. PLoS Biol 2: e363, 2004.
20. Kertesz M, Iovino N, Unnerstall U, Gaul U and Segal E: The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284, 2007. (Pubitemid 47482690)
21. Krek A, Grun D, Poy MN, et al: Combinatorial microRNA target predictions. Nat Genet 37: 495-500, 2005.
22. Sengupta S, Den Boon JA, Chen IH, et al: Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res 66: 7999-8006, 2006. (Pubitemid 44299164)
23. Reiner A, Yekutieli D and Benjamini Y: Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19: 368-375, 2003. (Pubitemid 36284936)
24. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC and Conklin BR: MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 4: R7, 2003.
25. Liu WH, Yeh SH, Lu CC, et al: MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 136: 683-693, 2009.
26. Dews M, Homayouni A, Yu D, et al: Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38: 1060-1065, 2006. (Pubitemid 44325933)
27. He L, He X, Lim LP, et al: A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134, 2007. (Pubitemid 47014436)
28. Tarasov V, Jung K Verdoodt B, et al: Differential regulation of microRNAs by p53 revealed by massively parallel sequencing. Cell Cycle 6: 1586-1593, 2007.
29. Welch C, Chen Y and Stallings RL: MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26: 5017-5022, 2007. (Pubitemid 47172643)
30. Yamakuchi M and Lowenstein CJ: MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 8: 712-715, 2009.
31. Reinhart BJ, Slack FJ, Basson M, et al: The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906, 2000. (Pubitemid 30130993)
32. Johnson CD, Esquela-Kerscher A, Stefani G, et al: The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67: 7713-7722, 2007. (Pubitemid 47281364)
33. Chen C, Ridzon DA, Broomer AJ, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179, 2005.
34. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat Rev Cancer 5: 505-515, 2005. (Pubitemid 40942827)
35. Zeng ZY, Zhou YH, Zhang WL, et al: Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 38: 120-133, 2007.
36. Shi W, Bastianutto C, Li A, et al: Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. Int J Cancer 119: 2467-2475, 2006. (Pubitemid 44546973)
37. Sumitsawan Y, Vaseenon V, Hanprasertpong C, Roongrotwattanasiri K, Chitapanarux I and Isaradisaikul S: High frequency hearing loss following treatment for nasopharyngeal carcinoma. J Med Assoc Thai 93: 324-329, 2010.
38. Chan SH, Ng WT, Kam KL, et al: Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Int J Radiat Oncol Biol Phys 73: 1335-1342, 2009.
39. Chen WC, Jackson A, Budnick AS, et al: Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer 106: 820-829, 2006. (Pubitemid 43238449)
40. Gunn GB, Villa RD, Sedler RR, Hardwicke F, Fornari GA and Mark RJ: Nasopharyngeal carcinoma metastasis to the pituitary gland: a case report and literature review. J Neurooncol 68: 87-90, 2004. (Pubitemid 39137354)
41. Ngan RK, Yiu HH, Cheng HK, Chan JK, Sin VC and Lau WH: Central nervous system metastasis from nasopharyngeal carcinoma: a report of two patients and a review of the literature. Cancer 94: 398-405, 2002. (Pubitemid 34081369)
42. Liang KL, Jiang RS, Lin JC, et al: Central nervous system infection in patients with postirradiated nasopharyngeal carcinoma: a case-controlled study. Am J Rhinol Allergy 23: 417-421, 2009.
43. Cerpa W, Toledo EM, Varela-Nallar L and Inestrosa NC: The role of Wnt signaling in neuroprotection. Drug News Perspect 22: 579-591, 2009.
44. Pelengaris S, Khan M and Evan G: c-MYC: more than just a matter of life and death. Nat Rev Cancer 2: 764-776, 2002. (Pubitemid 37328911)
45. Kim JW, Mori S and Nevins JR: Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate. Cancer Res 70: 4820-4828, 2010.
46. Cannell IG, Kong YW, Johnston SJ, et al: P38 MAPK/ MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci USA 107: 5375-5380, 2010.
47. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843, 2005. (Pubitemid 40839736)
48. Mott JL, Kurita S, Cazanave SC, Bronk SF, Werneburg NW and Fernandez-Zapico ME: Transcriptional suppression of mir-29b-1/ mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem 110: 1155-1164, 2010.
49. He L, Thomson JM, Hemann MT, et al: A microRNA polycistron as a potential human oncogene. Nature 435: 828-833, 2005. (Pubitemid 40839734)
50. Yamakuchi M, Ferlito M and Lowenstein CJ: miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 105: 13421-13426, 2008.
51. Boyerinas B, Park SM, Hau A, Murmann AE and Peter ME: The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 17: F19-F36, 2010.
52. Sun R, Fu X, Li Y, Xie Y and Mao Y: Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours. BMC Genomics 10: 93, 2009.
53. Mattie MD, Benz CC, Bowers J, et al: Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5: 24, 2006.
54. Zhang L, Volinia S, Bonome T, et al: Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA 105: 7004-7009, 2008. (Pubitemid 351754520)
55. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T and Hammond SM: Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20: 2202-2207, 2006.
56. Cheng C, Fu X, Alves P and Gerstein M: mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biol 10: R90, 2009.